Avaxim

Avaxim is a vaccine designed to prevent hepatitis A, a viral liver infection. It contains inactivated hepatitis A virus and is administered via intramuscular or subcutaneous injection.

Avaxim is used to protect against hepatitis A, a contagious liver disease caused by the hepatitis A virus. It is commonly recommended for individuals traveling to regions with high rates of hepatitis A, as well as for those at increased risk of exposure due to their lifestyle or occupation. The vaccine works by stimulating the body's immune system to produce antibodies against the virus, providing long-term protection.

Common effects of Avaxim may include mild soreness, redness, or swelling at the injection site. Some individuals may also experience temporary fatigue, headache, or low-grade fever. These effects are generally mild and short-lived, resolving within a few days.

Avaxim should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform the healthcare provider about any current illnesses or medications before receiving the vaccine.

Avaxim may interact with certain medications or other vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Avaxim. Additionally, individuals with weakened immune systems may have a reduced response to the vaccine.